SB 14 South Dakota Senate · 2026 Regular Session

modify provisions related to the practice of pharmacy.

SB 14 amends South Dakota's pharmacy practice laws by updating key definitions in §36-11-2 and §36-11-11. It clarifies terms like "compounding" (now including preparation based on routine prescribing patterns), "dispensing," and "interchangeable biological product" to align with federal standards. These changes directly affect pharmacists, pharmacy technicians, and pharmacy owners by defining their scope of practice and responsibilities more precisely. The bill focuses on administrative clarity rather than creating new requirements or restrictions.

Bill status signed all 5 stages cleared

Introduction

Jan 2026

Committee Review

Feb 2026

Senate Passage

Jan 2026

House Passage

Mar 2026

Signed into Law

Mar 2026

Introduced Jan 13, 2026 Signed Mar 9, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Introduced → Enrolled · 5 edits · Feb 26, 2026

MODERATE

This bill amends the South Dakota Pharmacy Practice Act to update and expand definitions related to pharmacy practice, particularly around biological products, drug compounding, and nonprescription drugs. The changes modernize terminology to align with federal standards and clarify the scope of pharmacy-related activities.

Scope change

The bill expands the scope of defined terms in the pharmacy chapter to include specific references to biological products, interchangeable biological products, and updated nonprescription drug regulations, making the law more current with federal standards.

DEFINITION

Added and updated definitions for 'Biological product' and 'Interchangeable biological product' to reference specific federal standards and dates (January 1, 2018 for biological products; January 1, 2025 for nonprescription drug regulations).

Added new definitions for 'Drug device' and 'Equivalent drug product' to clarify what equipment and products count as part of medication management systems.

Updated the definition of 'Nonprescription drugs' to include specific federal law references (21 U.S.C. § 352 and § 353) with January 1, 2025 effective dates, clarifying what drugs can be sold without prescriptions.

Added 'Patient counseling' and 'Pharmaceutical care' definitions to clarify the pharmacist's role in ensuring proper drug use and achieving therapeutic outcomes.

Added 'Registered pharmacy technician' definition to clarify the scope of tasks pharmacy technicians can perform under pharmacist supervision.

Floor votes · Senate Jan 27, 2026 · House Feb 25, 2026

How they voted

33–0

Passed · 2 other

Total votes 35

Jan 27, 2026

D Democratic3

3 Yea

100% Yea

R Republican32

30 Yea 2

93% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 9, 2026

Signed into law

Signed by the Governor on 2026-03-09 S.J. 488

executive

Mar 2, 2026

Lower · Passed

Signed by the Speaker H.J. 478

lower

Feb 26, 2026

Lower · Passed

Signed by the President S.J. 416

lower

Feb 25, 2026

Lower · Passed

House of Representatives Do Pass , Passed, YEAS 64, NAYS 0 H.J. 446

lower

Feb 24, 2026

Lower · Passed

Certified uncontested, placed on consent , Passed,

lower

Feb 24, 2026

Lower · Passed

Health and Human Services Do Pass , Passed, YEAS 12, NAYS 0

lower

Jan 28, 2026

Introduced

First read in House and referred to House Health and Human Services H.J. 165

lower

Jan 27, 2026

Upper · Passed

Senate Do Pass , Passed, YEAS 33, NAYS 0 S.J. 122

upper

Jan 26, 2026

Upper · Passed

Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 5

upper

Jan 13, 2026

Introduced

First read in Senate and referred to Senate Health and Human Services S.J. 13

upper

0 primary · 0 co-sponsors

What changed between versions

How they voted

Actions timeline

Sponsors